To all shareholders and shareholder representatives:
Jiangsu Shengtong Valve Co., Ltd. 2025 Annual Independent Director's Performance Report (Name: Yan Jun)
As an independent director of Jiangsu Shengtong Valve Co., Ltd. (hereinafter referred to as the "Company"), with a sense of responsibility to all shareholders, especially small and medium shareholders, I have strictly performed my duties as an independent director in 2025 in accordance with the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Norms for Operations of Main Board Listed Companies," and other laws and regulations, as well as the "Articles of Association" and the "Independent Director System." I actively attended relevant meetings, carefully reviewed all proposals submitted to the board of directors, and offered constructive suggestions for the company's business development and operations, thereby fully leveraging the role of an independent director and effectively safeguarding the overall interests of the company and the interests of all shareholders, especially small and medium shareholders. The following is a report on my performance as an independent director in 2025:
I. Basic Information of the Independent Director
(I) Personal Resume I, Yan Jun, born in 1982, am a Chinese national with no permanent residency abroad. I hold a bachelor's degree and am a certified public accountant. From July 2004 to March 2015, I served as a Senior Manager in the Audit Department of PricewaterhouseCoopers Zhong Tian LLP. From 2010 to 2013, I was seconded by PricewaterhouseCoopers as an external audit consultant for the Investment Banking Department of Guotai Junan Securities. From April 2015 to December 2017, I was a Partner at Shanghai Kingway Enterprise Management Consulting Co., Ltd. From December 2017 to August 2020, I served as the General Manager of Shanghai Kingway Investment Management Co., Ltd. From December 2020 to July 2024, I served as an independent director of Shanghai Blue Hao Electric Co., Ltd. From April 2020 to present, I have been the General Manager of Shanghai Junyu Enterprise Management Consulting Co., Ltd. From November 2019 to present, I have been an independent director of Shanghai Ailisi Pharmaceutical Technology Co., Ltd. From October 2023 to present, I have been the Executive Director and General Manager of Hangzhou Junfeng Information Technology Co., Ltd. From July 2019 to August 2025, I have served as an independent director of Jiangsu Shengtong Valve Co., Ltd.
(II) Independence Status As an independent director of the Company, I have self-inspected and confirmed that I meet the independence requirements for independent directors stipulated in the "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Norms for Operations of Main Board Listed Companies," and other relevant laws and regulations. There are no circumstances that affect my independence.
II. Overview of Independent Director's Annual Performance
(I) Attendance at Meetings With a spirit of responsibility to shareholders and a commitment to seeking truth from facts, I have diligently performed my duties and actively participated in all board of directors meetings, board special committee meetings, and shareholder meetings held by the Company in 2025. Before each meeting, I proactively familiarized myself with the relevant information of the proposals and obtained the necessary materials for decision-making. I actively communicated and exchanged information with the Company's senior management, gaining an understanding of the Company's production, operations, and business situation. Based on a thorough understanding of the actual situation and my professional capabilities and experience, I made independent judgments, expressed independent opinions, and voted on each proposal in accordance with the prescribed procedures, thereby playing a positive role in the board of directors' correct and scientific decision-making.